SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-089897
Filing Date
2023-08-10
Accepted
2023-08-10 17:18:49
Documents
13
Period of Report
2023-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2323468d1_8k.htm   iXBRL 8-K 24791
2 EXHIBIT 99.1 tm2323468d1_ex99-1.htm EX-99.1 66445
  Complete submission text file 0001104659-23-089897.txt   270829

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tmb-20230810.xsd EX-101.SCH 3012
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20230810_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20230810_pre.xml EX-101.PRE 22358
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2323468d1_8k_htm.xml XML 3210
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 231160702
SIC: 2834 Pharmaceutical Preparations